Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check5 days agoChange DetectedRheumatoid arthritis is now listed as a study topic, and related topics including MedlinePlus Genetics are added, expanding the page's navigational context and external resource connections.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s location entries were adjusted to reflect more precise geographic labels (e.g., “State of Vienna” and “Adazi, Latvia”) while removing older variants. The page version/revision indicator was also updated.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check48 days agoChange DetectedRelated topics 'Rheumatoid arthritis' and 'MedlinePlus Genetics' were removed from the page. The main study details remain unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.0 was added, replacing the previous v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded related topics 'Rheumatoid arthritis' and 'MedlinePlus Genetics' and updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.